Roivant Sciences LTD. (ROIV)

Ticker ROIV · SEC CIK 1635088 · Latest fiscal year ended Mar 31, 2026

Roivant Sciences LTD. reported revenue of $8.26M for the fiscal year ended Mar 31, 2026, down 71.6% from $29.05M the year before. Net income was a loss of $299.77M, a net margin of -3629.2% (prior year: −$171.98M). At the end of that fiscal year the company reported total assets of $5.71B and shareholders' equity of $4.53B.

Revenue

$8.26M

−71.6% vs prior year

Net income

−$299.77M

Net margin -3629.2%

Diluted EPS

−$0.54

USD per share

Total assets

$5.71B

At Mar 31, 2026

Equity

$4.53B

At Mar 31, 2026

Shares outstanding

722M

As of Jul 31, 2026

Roivant Sciences LTD. annual revenue, USD. Hover a bar for the exact figure.

Explore Roivant Sciences LTD.'s filings

Revenue by year — annual and quarterly revenue with growth rates
Income statement & cash flow — profit, margins, EPS and operating cash flow
Balance sheet — assets, liabilities, equity, cash and debt
SEC filings — 10-K and 10-Q filings with links to EDGAR

Latest SEC filings

Source: SEC EDGAR XBRL company facts for CIK 1635088 (raw data). Most recent filing in this dataset: 10-Q filed Aug 6, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.